Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (101-110 of 503) with videos related to

Pageof 51
Sort By:
Oncotarget|April 19, 2017
IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cellsVenkata Lokesh Battula, Khoa Nguyen, Jeff Sun, et al.
Nuklearmedizin. Nuclear Medicine|November 29, 2021
[Treatment Planning and Dose Verification for Combined Internal and External Radiotherapy (CIERT)]Robert Freudenberg, Holger Hartmann, Michael Andreeff, et al.
Leukemia|July 12, 2020
MDM2 inhibition: an important step forward in cancer therapyMarina Konopleva, Giovanni Martinelli, Naval Daver, et al.
Blood|August 27, 2011
p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12Kensuke Kojima, Teresa McQueen, Ye Chen, et al.
Plos One|March 14, 2013
The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in vitro and prevents breast cancer growth and metastasis in vivoXiaoyang Ling, Erika Spaeth, Ye Chen, et al.
Cancer Cell|December 13, 2017
Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic EfficacyRongqing Pan, Vivian Ruvolo, Hong Mu, et al.
Leukemia Research|December 23, 2003
An in vivo propagated human acute myeloid leukemia expressing ABCA3Kevin Norwood, Rui-Yu Wang, Charlotte Hirschmann-Jax, et al.
Cancer|April 2, 2011
Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profilingViolaine Havelange, Nicole Stauffer, Catherine C E Heaphy, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignanciesApostolia-Maria Tsimberidou, Deborah Thomas, Susan O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemiaJessica C Pahler, Stacey Ruiz, Irina Niemer, et al.
Pageof 51

Showing results (101-110 of 503) with videos related to

Sort By:
Pageof 51
Oncotarget|April 19, 2017
IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cellsVenkata Lokesh Battula, Khoa Nguyen, Jeff Sun, et al.
Nuklearmedizin. Nuclear Medicine|November 29, 2021
[Treatment Planning and Dose Verification for Combined Internal and External Radiotherapy (CIERT)]Robert Freudenberg, Holger Hartmann, Michael Andreeff, et al.
Leukemia|July 12, 2020
MDM2 inhibition: an important step forward in cancer therapyMarina Konopleva, Giovanni Martinelli, Naval Daver, et al.
Blood|August 27, 2011
p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12Kensuke Kojima, Teresa McQueen, Ye Chen, et al.
Plos One|March 14, 2013
The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in vitro and prevents breast cancer growth and metastasis in vivoXiaoyang Ling, Erika Spaeth, Ye Chen, et al.
Cancer Cell|December 13, 2017
Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic EfficacyRongqing Pan, Vivian Ruvolo, Hong Mu, et al.
Leukemia Research|December 23, 2003
An in vivo propagated human acute myeloid leukemia expressing ABCA3Kevin Norwood, Rui-Yu Wang, Charlotte Hirschmann-Jax, et al.
Cancer|April 2, 2011
Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profilingViolaine Havelange, Nicole Stauffer, Catherine C E Heaphy, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignanciesApostolia-Maria Tsimberidou, Deborah Thomas, Susan O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemiaJessica C Pahler, Stacey Ruiz, Irina Niemer, et al.
Pageof 51